Executive record

Laura Piccinini

Public governance roles and source-backed Claims for this individual.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:laura-piccinini-angoVersion: public-0As of: 2026-09-29

Not yet claimed8 published Claims2 sources

Key Claims

Biography

Laura Piccinini was appointed SVP and General Manager for Cardiovascular and International in January 2024, bringing more than 25 years of medical device industry experience. She previously served as CEO of Respiratory Motion, Inc., Global Head of Commercial Operations at Nobel Biocare Systems, and President of EMEA at Covidien and Stryker.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. 2025 to end not publishedExecutive title: Senior Vice President and General Manager, Cardiovascular and International · Organization not publishedANGO 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. ANGO 10-K executive officers

    sec filing · Source published: Jul 18, 2025 · Retrieved: May 14, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 14, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 14, 2026
    • Executive company: Executive at ANGIODYNAMICS INC · Claim reviewed: May 14, 2026
    • Executive title: Executive title: Senior Vice President and General Manager, Cardiovascular and International · Claim reviewed: May 14, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 14, 2026

  2. ANGO executive roster source

    sec filing · Source published: Date unavailable · Retrieved: May 3, 2026

    Supports 5 claims
    • AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
    • AI governance relevance: AI governance relevance: not identified in the cited filing · Claim reviewed: May 3, 2026
    • Executive company: Executive at ANGIODYNAMICS INC · Claim reviewed: May 14, 2026
    • Executive function: Other Executive (SVP) · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Senior Vice President and General Manager, Cardiovascular and International · Claim reviewed: May 14, 2026